ログイン
言語:

WEKO3

  • トップ
  • ランキング
To

Field does not validate

To

Field does not validate

To
lat lon distance


インデックスリンク

インデックスツリー

  • RootNode

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学術雑誌論文
  2. 小城 勝相

Effect of Nobiletin on Lipid Metabolism in Rats

https://ouj.repo.nii.ac.jp/records/8169
https://ouj.repo.nii.ac.jp/records/8169
5677af36-2400-4333-b36d-18302de04a95
名前 / ファイル ライセンス アクション
JHSNobiletin.pdf Effect of Nobiletin on Lipid Metabolism in Rats (254.8 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2014-07-22
タイトル
タイトル Effect of Nobiletin on Lipid Metabolism in Rats
タイトル
タイトル Effect of Nobiletin on Lipid Metabolism in Rats
言語 en
言語
言語 eng
キーワード
主題Scheme Other
主題 nobiletin
キーワード
主題Scheme Other
主題 high_density_lipoprotein
キーワード
主題Scheme Other
主題 cholesterol
キーワード
主題Scheme Other
主題 apolipoprotein_A-I
キーワード
主題Scheme Other
主題 white_adipose_tissue
キーワード
主題Scheme Other
主題 triglyceride
キーワード
言語 en
主題Scheme Other
主題 nobiletin
キーワード
言語 en
主題Scheme Other
主題 high_density_lipoprotein
キーワード
言語 en
主題Scheme Other
主題 cholesterol
キーワード
言語 en
主題Scheme Other
主題 apolipoprotein_A-I
キーワード
言語 en
主題Scheme Other
主題 white_adipose_tissue
キーワード
言語 en
主題Scheme Other
主題 triglyceride
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Nagata, Eri

× Nagata, Eri

WEKO 10138

Nagata, Eri

Search repository
Ichi, Ikuyo

× Ichi, Ikuyo

WEKO 10139

Ichi, Ikuyo

Search repository
Kataoka, Ryoko

× Kataoka, Ryoko

WEKO 10140

Kataoka, Ryoko

Search repository
著者別名
識別子Scheme WEKO
識別子 10141
姓名 Nagata, Eri
著者別名
識別子Scheme WEKO
識別子 10142
姓名 Ichi, Ikuyo
著者別名
識別子Scheme WEKO
識別子 10143
姓名 Kataoka, Ryoko
著者別名
識別子Scheme WEKO
識別子 10144
姓名 Matsushima, Miyuki
著者別名
識別子Scheme WEKO
識別子 10145
姓名 Adachi, Noriko
著者別名
識別子Scheme WEKO
識別子 10146
姓名 Kitamura, Yuko
著者別名
識別子Scheme WEKO
識別子 10147
姓名 Sasaki, Takao
著者別名
識別子Scheme WEKO
識別子 10148
姓名 Kojo, Shosuke
抄録
内容記述タイプ Abstract
内容記述 Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes and improves hyperglycemia and insulin resistance in obese (ob) diabetic ob/ob mice. We investigated the effects of nobiletin on lipid metabolism and accumulation of body fat in rats. The control group was fed a 20% high-fat diet and 1% cholesterol, and the nobiletin group was fed same diet supplemented with 0.1% (w/w) nobiletin. The rats were fed for 4 weeks. Weights of epididymal, perirenal, total white adipose tissues (WAT: mesenteric, perirenal, and epididymal), and the subcutaneous WAT in the nobiletin group were significantly lower than those in the control group. This decrease was brought about by nobiletin without affecting triglyceride (TG) levels in the liver and skeletal muscle. Plasma TG levels tended to be decreased by nobiletin. The size and diameter of WAT adipocytes in the nobiletin group were significantly lower than those in the control group. This decrease may be partly due to lower lipoprotein lipase (a major determinant for the development of obesity) levels in WAT of the nobiletin group than that of the control group. Plasma levels of high density lipoprotein cholesterol and apolipoprotein A-I increased significantly with administration of nobiletin. These results suggested a beneficial effect of nobiletin on lipid metabolism. However, no significant differences were observed between the nobiletin and the control groups in proteins such as ATP-binding cassette transporter A1, and sterol regulatory element-binding protein-1 in the liver, PPARγ and tumor necrosis factor-α (TNF-α) in WAT, and adiponectin and TNF-α in plasma.
内容記述
内容記述タイプ Other
内容記述 Nobiletin enhances differentiation and lipolysis of 3T3-L1 adipocytes and improves hyperglycemia and insulin resistance in obese (ob) diabetic ob/ob mice. We investigated the effects of nobiletin on lipid metabolism and accumulation of body fat in rats. The control group was fed a 20% high-fat diet and 1% cholesterol, and the nobiletin group was fed same diet supplemented with 0.1% (w/w) nobiletin. The rats were fed for 4 weeks. Weights of epididymal, perirenal, total white adipose tissues (WAT: mesenteric, perirenal, and epididymal), and the subcutaneous WAT in the nobiletin group were significantly lower than those in the control group. This decrease was brought about by nobiletin without affecting triglyceride (TG) levels in the liver and skeletal muscle. Plasma TG levels tended to be decreased by nobiletin. The size and diameter of WAT adipocytes in the nobiletin group were significantly lower than those in the control group. This decrease may be partly due to lower lipoprotein lipase (a major determinant for the development of obesity) levels in WAT of the nobiletin group than that of the control group. Plasma levels of high density lipoprotein cholesterol and apolipoprotein A-I increased significantly with administration of nobiletin. These results suggested a beneficial effect of nobiletin on lipid metabolism. However, no significant differences were observed between the nobiletin and the control groups in proteins such as ATP-binding cassette transporter A1, and sterol regulatory element-binding protein-1 in the liver, PPARγ and tumor necrosis factor-α (TNF-α) in WAT, and adiponectin and TNF-α in plasma.
書誌情報 Journal of Health Science
en : Journal of Health Science

巻 56, 号 6, p. 705-711, 発行日 2010
出版者
出版者 公益社団法人 日本薬学会
ISSN
収録物識別子タイプ ISSN
収録物識別子 1344-9702
書誌レコードID
収録物識別子タイプ NCID
収録物識別子 AA11316464
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-20 16:13:14.482381
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3